Presentation TCT 2015 Case 4: Where Are the Guidewires? Two-Stent Treatment Guided by OCT Presenter: Evald H. Christiansen, Andrejs Erglis, Michael Maeng October 12, 2015
Presentation TCT 2015 BIOSOLVE II: Evaluation of a Sirolimus-Eluting Bioresorbable Metallic Scaffold - Six-Month Clinical, Angiographic and Imaging Outcomes Presenter: Ioanna Kosmidou, Michael Haude October 12, 2015
Presentation TCT 2015 Transcatheter Valve Replacement for Native Mitral Stenosis: International Registry Results Presenter: Michael J. Mack, Francesco Maisano, Mayra Guerrero October 12, 2015
Presentation TCT 2015 Transcatheter Valve Replacement for Mitral Bioprosthetic Valve and Ring Annuloplasty Failures: Multicenter VIVID Registry Results Presenter: Michael J. Mack, Francesco Maisano, Danny Dvir October 12, 2015
Presentation TCT 2015 Preoperative Planning for Mitral Valve-in-Valve/Ring Procedures: Integrating Imaging and the Mitral App Presenter: Michael J. Mack, Francesco Maisano, Vinayak Bapat October 12, 2015
Presentation TCT 2015 CT Imaging to Guide Selection and Treatment for Transcatheter MV Replacement Presenter: Michael J. Mack, Francesco Maisano, Jonathon A. Leipsic October 12, 2015
Presentation TCT 2015 Failure Modes for Transcatheter MV Replacement and Their Implications: Paravalvular Leaks, LVOT, Embolization, and More Presenter: Michael J. Mack, Francesco Maisano, Paul Sorajja October 12, 2015
Presentation TCT 2015 Access Site Alternatives for Transcatheter MV Replacement: Transatrial, Transapical, or Transeptal? Presenter: Michael J. Mack, Francesco Maisano, Nicolo Piazza October 12, 2015
Presentation TCT 2015 Is Hemodynamic Collapse Due to Increased Afterload After MV Replacement in Severe MR With Reduced LVEF a Real Phenomenon? Presenter: Michael J. Mack, Francesco Maisano, Patrick M. McCarthy October 12, 2015
Presentation TCT 2015 For Years Weve Been Hearing Surgical MV Repair Is Always Preferable to Replacement So, Why Transcatheter MV Replacement?! Presenter: Michael J. Mack, Francesco Maisano, John G. Webb October 12, 2015
Presentation TCT 2015 PROMISE FFR-CT: Evaluation of FFR-CT in Patients Undergoing Computed Tomographic Angiography for Evaluation of Suspected Coronary Artery Disease Presenter: Spencer B. King III, Jagat Narula, Michael Lu October 12, 2015
Presentation TCT 2015 BIOSOLVE II: Evaluation of a Sirolimus-Eluting Bioresorbable Metallic Scaffold Six-Month Clinical, Angiographic, and Imaging Outcomes Presenter: Dean J. Kereiakes, Ron Waksman, Davide Capodanno, Michael Haude October 12, 2015
Presentation TCT 2015 Valvular Heart Disease: Treatment of Mitral Stenosis and Mitral Regurgitation Presenter: Michael J. Lim, Molly Szerlip October 12, 2015
Presentation TCT 2015 The Effect of the Mitochondrial Protective Agent Bendavia on Infarct Size, Left Ventricular Remodeling, and Left Ventricular Function Presenter: Robert A. Kloner, William W. O'Neill, C. Michael Gibson October 11, 2015
Presentation TCT 2015 Debate: Repair vs Replacement for Secondary MR: Replacement Always! Presenter: Michael J. Mack, Patrick M. McCarthy October 11, 2015
Presentation TCT 2015 Debate: Repair vs Replacement for Secondary MR: Repair Always! Presenter: Michael J. Mack, Patrick M. McCarthy, Khalil Fattouch October 11, 2015
Presentation TCT 2015 Do Different Rings Really Make a Difference in Primary MR? In Secondary MR? Presenter: Michael J. Mack, Patrick M. McCarthy, Robert A. Guyton October 11, 2015
Presentation TCT 2015 Beyond the Undersized Ring for Secondary MR: Adjunctive Techniques for Repair Presenter: Michael J. Mack, Patrick M. McCarthy, Khalil Fattouch October 11, 2015
Presentation TCT 2015 Residual and Recurrent MR After MV Repair and Replacement: What Is the Data (for Primary vs Secondary MR)? Presenter: Michael J. Mack, Patrick M. McCarthy, Allan Schwartz October 11, 2015
Presentation TCT 2015 Update on Boston Scientifics REINFORCE Presenter: Farrell O. Mendelsohn, William B. White, Michael A. Weber October 11, 2015